PharmaDrug Inc (CSE:BUZZ) (OTCMKTS:LMLLF) CEO Daniel Cohen tells Proactive its subsidiary Sairiyo Therapeutics Inc, a biotechnology company developing Cepharanthine, a repurposed naturally-derived compound for the potential treatment of cancer and other diseases, has tapped two experts to join its newly-formed scientific and clinical advisory board.
Cohen says that drug-repurposing expert Moshe Rogosnitzky has joined as an advisor, with more than 15 years of experience in the use of Cepharanthine for treating advanced cancers, as well as androgenic alopecia, or male-pattern baldness. Along with him is gastric cancer expert Yelena Janjigian, who has joined as an advisor. She is the chief of the Gastrointestinal Medical Oncology Service in the Division of Solid Tumor Oncology within the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK) in New York.